Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:advantage |
preserves viable cells
ready-to-use allograft |
| gptkbp:alternativeTo |
autologous chondrocyte implantation
microfracture |
| gptkbp:appliesTo |
orthopedic surgeons
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:contains |
gptkb:bone
extracellular matrix viable chondrocytes |
| https://www.w3.org/2000/01/rdf-schema#label |
Cartiform
|
| gptkbp:implantationMethod |
surgical implantation
|
| gptkbp:indication |
focal cartilage lesions
knee cartilage defects |
| gptkbp:manufacturer |
Arthrex, Inc.
|
| gptkbp:material |
cryopreserved osteochondral allograft
|
| gptkbp:storage |
cryopreserved
|
| gptkbp:usedFor |
cartilage repair
treatment of cartilage defects |
| gptkbp:bfsParent |
gptkb:Osiris_Therapeutics
|
| gptkbp:bfsLayer |
8
|